Clinical trial
Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis
NCT00282438 · Northwestern University, Other · Terminated
Key facts
| NCT number | NCT00282438 |
|---|---|
| Title | Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis |
| Official title | Hematopoietic Stem Cell Transplant in Patients With Refractory Sarcoidosis: A Phase I/II Trial |
| Lead sponsor | Northwestern University, Other |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoidosis |
| Intervention type | Biological |
| Interventions | Autologous hematopoietic stem cell transplantation, Allogeneic stem cell transplantation |
| Enrollment | 2 |
| Start date | Dec 1, 2003 |
| Primary completion | Aug 1, 2015 |
| Completion | Aug 1, 2015 |
| First posted | Jan 26, 2006 |
| Last update posted | Aug 31, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: